Features of the long-term dynamics of heart rate variability among workers of a potash ore processing enterprise

Introduction. Currently, the violation of heart rate variability as one of the main pathogenetic mechanisms of the damaging effect of pollutants, associated effects on the cardiovascular system.

The study aims to explore the dynamics of the influence of the autonomic nervous system (ANS) on heart rate variability (HRV) in workers of a potassium ore processing enterprise exposed to industrial pollutants (fine fractions of potassium chloride dust, formaldehyde, hexane, heptane) with an assessment of changes in dependence from work experience, establishment of cause-and-effect relationships of violations of heart rate variability with exposure to chemical compounds.

Materials and methods. The object of the study was 140 employees of a potash ore processing enterprise, assigned to the observation group, and 76 employees of the administrative and technical apparatus, who made up the comparison group. Samples were taken from the air of the working medium for the content of saturated hydrocarbons (hexane, heptane), the vapors of formhehyde were considered, and the presence of fine particles PM_2.5 and PM₁₀ was established. Investigation of biological media (blood, urine) of workers at the enterprise determination of formaldehyde in blood, hexane and heptane in urine. Evaluation of heart rate variability was carried out on a computer electrocardiograph "Poli-Spectr-8/EX" using a cardiorhythmographic program using the method of time analysis, variation pulsometry and spectral analysis.

Results. The concentration of fine particles in the air at the workplaces of the observation group was 12–111 times higher for PM_2.5, and 5.6–74.6 times higher for PM₁₀ than for the work places of the comparison group. The concentration of formaldehyde, hexane and heptane in the air did not exceed hygienic standards. In the observation group relative to the comparison group, formaldehyde blood was 1.5 times (p<0.001), in the urine of hexane — 1.2 times (p=0.011), heptane — 1.3 times (p=0.046). It was found that with an experience of up to 10 years, formaldehyde in the blood of workers in the observation group was 1.4 times higher than that in the comparison group (p=0.011), with an experience of more than 10 years — 1.7 times (p=0.005). In the urine of workers in the observation group with work experience of up to 10 years, an excess of 1.3 (p=0.026) relative to the comparison group of hexane was found. HRV data analysis. With damage to the length of service in the observation group, there was a significant decrease in the temporal analysis indicators (SDNN, ms, RMSSD, ms, pNN50, %, CV, %), while in the comparison group, only the CV, % decrease was statistically significant; the values of IN conventional units, AMo, % significantly increased (p=0.03 and p=0.003, respectively). A statistically significant relationship was established between the likelihood of an increase depending on the content of heptane in urine (b₀=0.22; b₁=10.6; F=21.5; R²=0.09; p=0.0001) and formaldehyde in the blood (b₀=0.02; b₁=6.55; F=69.6; R²=0.25; p=0.0001) in the surveyed workers.

Conclusions. Activation of central ergotropic and humoral-metabolic mechanisms, a tendency towards a decrease in parasympathetic influences. The method of logistic regression analysis established a statistically significant relationship between the probability of an increase in the stress index depending on the heptane content in the blood of the surveyed suppliers.

1. Abdelnabi M.H. Cardiovascular Clinical Implications of Heart Rate Variability. Int. J. Cardiovasc. Acad. 2019; 5: 37-41. https://doi.org/10.4103/IJCA.IJCA_36_18

2. Urbanik D., Podgórski M., Mazur G. Heart rate variability - clinical significance. Fam. Med. Prim. Care Rev. 2018; 20(1): 87-90. https://doi.org/10.5114/fmpcr.2018.73710

3. Billman G.E., Huikuri H.V., Sacha J., Trimmel K. An introduction to heart rate variability: methodological considerations and clinical applications. Front. Physiol. 2015; 6: 55. https://doi.org/10.3389/fphys.2015.00055

4. Camm A., Malik M., Bigger J., Breithardt G., Cerutti S., Cohen R. et al. Heart rate variability: Standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation. 1996; 93: 1043-1065. https://doi.org/10.1161/01.CIR.93.5.1043

5. Sacha J. Interaction between heart rate and heart rate variability. Ann. Noninvasive Electrocardiol. 2014; 19, 207-216. https://doi.org/10.1111/anec.12148

6. Goldenberg I., Goldkorn R., Shlomo N., Einhorn M., Levitan J., Kuperstein R., Klempfner R., Johnson B. Heart Rate Variability for Risk Assessment of Myocardial Ischemia in Patients Without Known Coronary Artery Disease: The HRV-DETECT (Heart Rate Variability for the Detection of Myocardial Ischemia) Study. Journal of the American Heart Association. 2019; 8. (24): e014540. https://doi.org/10.1161/JAHA.119.014540

7. Compostella L., Lakusic N., Compostella C., Truong L.V., Iliceto S., Bellotto F. Does heart rate variability correlate with long-term prognosis in myocardial infarction patients treated by early revascularization? World journal of cardiology. 2017; 9(1): 27-38. https://doi.org/10.4330/wjc.v9.i1.27

8. Brateanu A. Heart rate variability after myocardial infarction: what we know and what we still need to find out. Curr Med Res Opin. 2015; 31: 1855-60. https://doi.org/10.1185/03007995.2015.1086992

9. Coviello I., Pinnacchio G., Laurito M., Stazi A., Battipaglia I., Barone L., Mollo R., Russo G., Villano A., Sestito A. et al. Prognostic role of heart rate variability in patients with ST-segment elevation acute myocardial infarction treated by primary angioplasty. Cardiology. 2013; 124: 63-70. https://doi.org/10.1159/000345779

10. La Rovere M.T., Pinna G.D., Maestri R., Barlera S., Bernardinangeli M., Veniani M., Nicolosi G.L., Marchioli R., Tavazzi L. Autonomic markers and cardiovascular and arrhythmic events in heart failure patients: still a place in prognostication? Data from the GISSI-HF trial. Eur. J. Heart Fail. 2012; 14(12): 1410-9. https://doi.org/10.1093/eurjhf/hfs126

11. Chen C.H., Huang P.W., Tang S.C. et al. Complexity of heart rate variability can predict stroke-in-evolution in acute ischemic stroke patients. Sci Rep. 2015; 5(17552): 1-5. https://doi.org/10.1038/srep17552

12. Saito I., Takata Y., Maruyama K., Eguchi E., Kato T., Shirahama R., Tomooka K., Kawamura R., Sano M., Tabara Y., Osawa H., Tanigawa T. Association Between Heart Rate Variability and Home Blood Pressure: The Toon Health Study. American Journal of Hypertension. 2018; 31(10). 1120-6. https://doi.org/10.1093/ajh/hpy100

13. Carthy E.R. Autonomic dysfunction in essential hypertension: A systematic review. Ann Med Surg. 2013; 3(1): 2-7. https://doi.org/10.1016/j.amsu.2013.11.002

14. Franklin B.A., Brook R., Pope C.A. Air pollution and cardiovascular disease. Curr. Probl. Cardiol. 2015; 40: 207-238. https://doi.org/10.1016/j.cpcardiol.2015.01.003

15. Sanidas E.J., Papadopoulos P.D., Grassos H., Velliou M., Tsioufis R., Barbetseas J. Air pollution and arterial hypertension. A new risk factor is in the air. J. Am. Soc. Hypertens. 2017; 11: 709-715. https://doi.org/10.1016/j.jash.2017.09.008

16. Park S.K., Auchincloss A.H., O'Neill M.S., Prineas R., Correa J.C., Keeler J., Barr R.G., Kaufman J.D., Diez Roux A.V. Particulate air pollution, metabolic syndrome, and heart rate variability: the multi-ethnic study of atherosclerosis (MESA). Environmental health perspectives. 2010; 118(10): 1406-11. https://doi.org/10.1289/ehp.0901778

17. Pieters N., Plusquin М., Cox B., Kicinski M., Vanronsveld J., Nawrot T.S. An epidemiological appraisal of the association between heart rate variability and particulate air pollution: a meta-analysis. Heart. 2012; 98: 1127-1135. https://doi.org/10.1136/heartjnl-2011-301505

18. Cosselman K.E., Navas-Acien A., Kaufman J.D. Environmental factors in cardiovascular disease. Nat. rev. cardiol. 2015; 12: 627-642. https://doi.org/10.1038/nrcardio.2015.152

19. Zanobetti A., Stone P.H., Speizer F.E., Schwartz J.D., Coull B.A., Suh H.H., Nearing B.D., Mittleman M.A., Verrier R.L., Gold D.R. T-wave alternans, air pollution and traffic in high-risk subjects. The American journal of cardiology. 2009; 104(5): 665-670. https://doi.org/10.1016/j.amjcard.2009.04.046

20. Cakmak S., Dales R., Kauri L.M., Mahmud M., Ryswyk K.V., Vanos J. et al. Metal composition of fine particulate air pollution and acute changes in cardiorespiratory physiology. Environ. Pollut. 2014; 189: 208-14. https://doi.org/10.1016/j.envpol.2014.03.004

21. Lee M.S., Eum K.D., Fang S.C., Rodrigues E.G., Modest G.A., Christiani D.C. Oxidative stress and systemic inflammation as modifiers of cardiac autonomic responses to particulate air pollution. International journal of cardiology. 2014; 176(1): 166-70. https://doi.org/10.1016/j.ijcard.2014.07.012

22. Anderson H.R., Armstrong B., Hajat S., Harrison R., Monk V., Poloniecki J., Timmis A., Wilkinson P. Air pollution and activation of implantable cardioverter defibrillators in London. Epidemiology. 2010; 21(3): 405-13. https://doi.org/10.1097/EDE.0b013e3181d61600

23. Langrish J.P., Watts S.J., Hunter A.J., Shah A.S., Bosson J.A., Unosson J., Barath S., Lundbäck M., Cassee F.R., Donaldson K., Sandström T., Blomberg A., Newby D.E., Mills N.L. Controlled exposures to air pollutants and risk of cardiac arrhythmia. Environ Health Perspect. 2014; 122(7): 747-53. https://doi.org/10.1289/ehp.1307337

24. Niu Z., Liu F., Li B., Li N., Yu H., Wang Y., Tang H., Chen X., Lu Y., Cheng Z., Liu S., Chen G., Zhang Y., Xiang H. Acute effect of ambient fine particulate matter on heart rate variability: an updated systematic review and meta-analysis of panel studies. Environ Health Prev Med. 2020; 25(1): 77. https://doi.org/10.1186/s12199-020-00912-2

25. Buteau S., Goldberg M.S. A structured review of panel studies used to investigate associations between ambient air pollution and heart rate variability. Environ Res. 2016; 148: 207-47. https://doi.org/10.1016/j.envres.2016.03.013

26. Liao D., Shaffer M.L., Rodriguez-Colon S., He F., Li X., Wolbrette D.L., Yanosky J., Cascio W.E. Acute adverse effects of fine particulate air pollution on ventricular repolarization. Environ Health Perspect. 2010 Jul; 118(7): 1010-5. https://doi.org/10.1289/ehp.0901648

27. Sivagangabalan G., Spears D., Masse S., Urch B., Brook R.D., Silverman F. et al. The effect of air pollution on spatial dispersion of myocardial repolarization in healthy human volunteers. J. Am. Coll. Cardio. 2011; 57: 198-206. https://doi.org/10.1016/j.jacc.2010.08.625

28. Barbosa C.M.G., Terra-Filho M., de Albuquerque A.L.P., Di Giorgi D., Grupi C. et al. Burnt Sugarcane Harvesting - Cardiovascular Effects on a Group of Healthy Workers, Brazil. Plos One. 2012; 7(9): e46142. https://doi.org/10.1371/journal.pone.0046142

29. Weichenthal S., Kulka R., Bélisle P., Joseph L., Dubeau A., Martin C., Wang D., Dales R. Personal exposure to specific volatile organic compounds and acute changes in lung function and heart rate variability among urban cyclists. Environmental Research. 2012; 118: 118-23. https://doi.org/10.1016/j.envres.2012.06.005

30. Mizukoshi A., Kumagai K., Yamamoto N., Noguchi M., Yoshiuchi K., Kumano H., Sakabe K., Yanagisawa Y. In-situ Real-Time Monitoring of Volatile Organic Compound Exposure and Heart Rate Variability for Patients with Multiple Chemical Sensitivity. International Journal of Environmental Research and Public Health. 2015; 12(10): 12446-65. https://doi.org/10.3390/ijerph121012446